These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1424509)

  • 21. In vitro activities of two oxazolidinone antimicrobial agents, DuP 721 and DuP 105.
    Neu HC; Novelli A; Saha G; Chin NX
    Antimicrob Agents Chemother; 1988 Apr; 32(4):580-3. PubMed ID: 3377467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria.
    Jorgensen JH; Maher LA; Redding JS
    Eur J Clin Microbiol; 1987 Feb; 6(1):91-6. PubMed ID: 3032612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M
    Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro antibacterial activity of FK037, a new parenteral broad-spectrum cephalosporin, against recent clinical isolates in the fields of obstetrics and gynecology.
    Mikamo H; Izumi K; Ito K; Katoh N; Watanabe K; Ueno K; Tamaya T
    Chemotherapy; 1994; 40(3):161-6. PubMed ID: 8205934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones.
    Jones RN; Johnson DM; Erwin ME
    Antimicrob Agents Chemother; 1996 Mar; 40(3):720-6. PubMed ID: 8851600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates.
    King A; Phillips I
    J Antimicrob Chemother; 2001 Aug; 48(2):219-23. PubMed ID: 11481291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antibacterial activity of trospectomycin (U-63,366F) against anaerobic bacteria and aerobic gram-positive cocci in Chile.
    Montiel F; Kaltwasser G; Pinto ME; Lam M
    Diagn Microbiol Infect Dis; 1991; 14(3):259-64. PubMed ID: 1832369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes.
    Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(7):431-4. PubMed ID: 3836865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vitro and in vivo activities of six new monofluoroquinolone and difluoroquinolone 3-carboxylic acids with a 7-azetidin ring substituent.
    Gargallo-Viola D; Esteve M; Moros M; Coll R; Xicota MA; de Andres C; Roser R; Guinea J
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2318-26. PubMed ID: 2088187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua.
    Cáceres M; Carrera E; Palma A; Berrios G; Weintraub A; Nord CE
    Rev Esp Quimioter; 1999 Dec; 12(4):332-9. PubMed ID: 10855012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds.
    Goldstein EJ; Citron DM; Merriam CV; Tyrrell KL
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):347-51. PubMed ID: 23623385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity and beta-lactamase stability of the new oral cephalosporin Bay v 3522.
    Chin NX; Gu JW; Neu HC
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):685-91. PubMed ID: 2226499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F
    Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS; Mazens-Sullivan MF; Bartlett RC
    Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The in vitro activity of the combination of daptomycin and metronidazole against Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus spp., and Bacteroides spp.
    Werner H; Nagy E; Heizmann WR
    J Chemother; 1989 Jul; 1(4 Suppl):207-8. PubMed ID: 16312371
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3959-62. PubMed ID: 16982780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms.
    Lauterwein M; Oethinger M; Belsner K; Peters T; Marre R
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2541-3. PubMed ID: 8585741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of cefcanel versus other oral cephalosporins.
    Chin NX; Gu JW; Neu HC
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):676-82. PubMed ID: 1748125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.